Old Web
English
Sign In
Acemap
>
authorDetail
>
Rosa María Jiménez Escribano
Rosa María Jiménez Escribano
Internal medicine
Adverse effect
Propranolol
Von Hippel–Lindau disease
Biomarker (medicine)
3
Papers
24
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Oral Propranolol in Von Hippel Lindau Ocular Affection
2021
Beatriz González Rodríguez
María González-Rodríguez
Natalia Bejarano Ramírez
Rosa María Jiménez Escribano
Francisco Javier Redondo Calvo
Show All
Source
Cite
Save
Citations (0)
Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial
2019
Beatriz González Rodríguez
Karina Villar Gómez de las Heras
Daniel T. Aguirre
Luis Rodríguez Padial
Virginia Albiñana
Lucía Recio-Poveda
Angel Cuesta
Luisa Mª. Botella
Rosa María Jiménez Escribano
Show All
Source
Cite
Save
Citations (5)
Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease
2017
Orphanet Journal of Rare Diseases
Virginia Albiñana
Rosa María Jiménez Escribano
Isabel Soler
Luis Rodríguez Padial
Lucía Recio-Poveda
Karina Villar Gómez de las Heras
Luisa María Botella
Show All
Source
Cite
Save
Citations (19)
1